What people are saying.

September 14, 2018

Allogene Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering

July 11, 2018

Allogene Therapeutics Announces Scientific Advisory Board

May 30, 2018

Allogene Therapeutics Announces Board of Directors

May 23, 2018

Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing

May 15, 2018

Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline

April 3, 2018

Cellectis and Allogene Therapeutics Intend to Continue Strategic Cancer Immunotherapy Collaboration to Accelerate Development and Commercialization of Allogeneic Off-the-Shelf CAR T Therapies